EMD-14886

Single-particle
3.7 Å
EMD-14886 Deposition: 03/05/2022
Map released: 01/06/2022
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-14886

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7zr8 summary report (pdf.gz) Map-7zr8 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement)

EMD-14886

Single-particle
3.7 Å
EMD-14886 Deposition: 03/05/2022
Map released: 01/06/2022
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2, Enterobacteria phage T4
Sample: OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
Fitted models: 7zr8

Deposition Authors: Duyvesteyn HME, Ren J , Stuart DI
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.
PUBMED: 35662412
DOI: doi:10.1016/j.cell.2022.05.014
ISSN: 1097-4172